Philippe R. Bovy

1.3k citations

40 papers · 1.1k indexed · h-index 19

Co-authors: Sylvain Rault Valérie Collot Gillian M. Olins Jean‐Charles Lancelot Alexandre Bouillon Joseph G. Rico Ronald Breslow Patrick Dallemagne
Topics: Chemical Synthesis and Analysis (11 papers)Catalytic Cross-Coupling Reactions (6 papers)Heart Failure Treatment and Management (4 papers)
Cited by: Organic Chemistry Cardiology and Cardiovascular Medicine Pharmaceutical Science
Journals: Journal of the American Chemical Society Journal of Biological Chemistry Hypertension
Partner nations: United States France Belgium

In The Last Decade

Philippe R. Bovy

39 papers receiving 1.0k citations

Peers

Countries citing papers authored by Philippe R. Bovy

Since Specialization

Citations

This map shows the geographic impact of Philippe R. Bovy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe R. Bovy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe R. Bovy more than expected).

Fields of papers citing papers by Philippe R. Bovy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe R. Bovy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe R. Bovy. The network helps show where Philippe R. Bovy may publish in the future.

Co-authorship network of co-authors of Philippe R. Bovy

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe R. Bovy. A scholar is included among the top collaborators of Philippe R. Bovy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe R. Bovy. Philippe R. Bovy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthesis of a Novel Class of Non-Peptide NK-2 Receptor Ligand, Derived from 1-Phenyl-3-pyrrol-1-ylindan-2-carboxamides 2002 ·Bioorganic & Medicinal Chemistry ·Jean Guillon,Patrick Dallemagne,Jean‐Michel Léger,Jana Sopková,Philippe R. Bovy,Christian Jarry,Sylvain Rault	22
2	Synthesis of novel halopyridinylboronic acids and esters. Part 3: 2, or 3-Halopyridin-4-yl-boronic acids and esters 2002 ·Tetrahedron ·Alexandre Bouillon,Jean‐Charles Lancelot,Valérie Collot,Philippe R. Bovy,Sylvain Rault	53
3	Enantioselective Sharpless Dihydroxylation of Vinylic Aromatic Heterocycles 2000 ·Synthesis ·(unknown),(unknown),(unknown),(unknown),(unknown),Philippe R. Bovy	2
4	Synthesis of new pyrrolo[2,1-b]quinazolinones by original rearrangement of pyrrolo[2,1-c][1,4]benzodiazepines 1998 ·Tetrahedron Letters ·(unknown),Frédéric Fabis,Philippe R. Bovy,Philippe Ochsenbein,Sylvain Rault	7
5	Asymmetric synthesis of both enantiomers of 2-(dimethylamino)-1-[3-methoxy-2-(1-methylethoxy)phenyl]ethanol 1997 ·European Journal of Medicinal Chemistry ·(unknown),(unknown),Philippe R. Bovy,(unknown),I. Angel,Guy Georges,Philippe Ochsenbein	1
6	A novel series of orally active antiplatelet agents 1995 ·Bioorganic & Medicinal Chemistry ·Jeffery A. Zablocki,Foe S. Tjoeng,Philippe R. Bovy,Masateru Miyano,Robert B. Garland,Kenneth Williams,(unknown),Mark E. Zupec,Joseph G. Rico,(unknown),Mihaly V. Toth,(unknown),Steven P. Adams,Susan G. Panzer‐Knodle,Nancy S. Nicholson,(unknown),Anita K. Salyers,(unknown),(unknown),Larry P. Feigen	30
7	Potent in Vitro and in Vivo Inhibitors of Platelet Aggregation Based Upon the Arg-Gly-Asp Sequence of Fibrinogen. (Aminobenzamidino)succinyl (ABAS) Series of Orally Active Fibrinogen Receptor Antagonists 1995 ·Journal of Medicinal Chemistry ·(unknown),Joseph G. Rico,Robert B. Garland,Thomas E. Rogers,Kenneth Williams,(unknown),(unknown),Philippe R. Bovy,Foe S. Tjoeng	86
8	The importance of quadrupolar interactions in molecular recognition processes involving a phenyl group 1994 ·Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) ·Michel Luhmer,Kristin Bartik,Annick Dejaegere,Philippe R. Bovy,Jacques Reisse	13
9	Design of orally active, non-peptide fibrinogen receptor antagonists. An evolutionary process from the RGD sequence to novel anti-platelet aggregation agents 1994 ·Bioorganic & Medicinal Chemistry ·Philippe R. Bovy,F. S. TJOENG,(unknown),Thomas E. Rogers,(unknown),Jeffery A. Zablocki,Robert B. Garland,(unknown),Henry E. Dayringer,Máté Tóth,Mark E. Zupec,Shashidhar N. Rao,Susan G. Panzer‐Knodle,Nancy S. Nicholson,Anita K. Salyers,(unknown),M. Hérin,Masateru Miyano,Larry P. Feigen,S P Adams	10
10	ChemInform Abstract: A Highly Stereoselective Michael Addition to an α,β‐ Unsaturated Ester as the Crucial Step in the Synthesis of a Novel . beta.‐Amino Acid‐Containing Fibrinogen Receptor Antagonist. 1994 ·ChemInform ·(unknown),(unknown),Thomas E. Rogers,Philippe R. Bovy	1
11	Nonpeptide angiotensin II antagonists: N-phenyl-1H-pyrrole derivatives are angiotensin II receptor antagonists 1993 ·Journal of Medicinal Chemistry ·Philippe R. Bovy,David B. Reitz,Joseph T. Collins,(unknown),Gillian M. Olins,(unknown),Ellen G. McMahon,Maria A. Palomo,J P Koepke,(unknown),(unknown),Jeffrey F. Gaw	34
12	A highly stereoselective Michael addition to an .alpha.,.beta.-unsaturated ester as the crucial step in the synthesis of a novel .beta.-amino acid-containing fibrinogen receptor antagonist 1993 ·The Journal of Organic Chemistry ·Joseph G. Rico,(unknown),Thomas E. Rogers,Philippe R. Bovy	47
13	Influence of polyfluorination of the phenylalanine ring of angiotensin II on conformation and biological activity 1991 ·Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology ·Philippe R. Bovy,Daniel P. Getman,John Matsoukas,Graham J. Moore	13
14	Conformationally restricted polysubstituted biphenyl derivatives with angiotensin II receptors antagonist properties 1991 ·Journal of Medicinal Chemistry ·Philippe R. Bovy,Joseph T. Collins,Gillian M. Olins,Ellen G. McMahon,William Hutton	23
15	Structure-activity relationships for the carboxy-terminus-truncated analogs of angiotensin II, a new class of angiotensin II antagonists 1990 ·Journal of Medicinal Chemistry ·Philippe R. Bovy,(unknown),Gillian M. Olins,(unknown),Ellen G. McMahon,M.J. Palomo,J P Koepke,K.Shahid Salles,Angelo J. Trapani	11
16	Atriopeptin Regulation and Renal Function in Conscious Spontaneously Hypertensive Rats 1990 ·American Journal of Hypertension ·J P Koepke,(unknown),Pramod P. Mehta,Gillian M. Olins,Angelo J. Trapani,(unknown),Philippe R. Bovy,Kerry L. Spear,Edward H. Blaine	6
17	Structure activity in the atrial natriuretic peptide (ANP) family 1990 ·Medicinal Research Reviews ·Philippe R. Bovy	50
18	A carboxy-terminus truncated analog of angiotensin II, [Sar1]angiotensin II-(1-7)-amide, provides an entry to a new class of angiotensin II antagonists 1989 ·Journal of Medicinal Chemistry ·Philippe R. Bovy,(unknown),Ellen G. McMahon,Maria A. Palomo	14
19	Specific inhibitors of endopeptidase 24.11 inhibit the metabolism of atrial natriuretic peptides in vitro and in vivo 1989 ·Molecular and Cellular Endocrinology ·Gillian M. Olins,Philip A. Krieter,Angelo J. Trapani,Kerry L. Spear,Philippe R. Bovy	62
20	Interaction of non-guanylate cyclase-linked atriopeptin receptor ligand and endopeptidase inhibitor in conscious rats. 1989 ·Journal of Pharmacology and Experimental Therapeutics ·J P Koepke,(unknown),Angelo J. Trapani,Philippe R. Bovy,Kerry L. Spear,Gillian M. Olins,Edward H. Blaine	38

About Philippe R. Bovy

Philippe R. Bovy is a scholar working on Organic Chemistry, Cardiology and Cardiovascular Medicine and Pharmaceutical Science, having authored 40 papers that have together received 1.1k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (11 papers), Catalytic Cross-Coupling Reactions (6 papers) and Heart Failure Treatment and Management (4 papers). The work is most often cited by research in Organic Chemistry (561 citations), Cardiology and Cardiovascular Medicine (235 citations) and Pharmaceutical Science (42 citations). Philippe R. Bovy has collaborated with scholars based in United States, France and Belgium. Frequent co-authors include Sylvain Rault, Valérie Collot, Gillian M. Olins, Jean‐Charles Lancelot, Alexandre Bouillon, Joseph G. Rico, Ronald Breslow, Patrick Dallemagne, Thomas E. Rogers and Angelo J. Trapani. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Hypertension.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact